News / Health

Researchers Warn Against TB Drug-Resistance

A patient who tested positive for extreme drug resistant tuberculosis awaits treatment at a rural hospital at Tugela Ferry in South Africa's impoverished KwaZulu Natal province, (File photo).
A patient who tested positive for extreme drug resistant tuberculosis awaits treatment at a rural hospital at Tugela Ferry in South Africa's impoverished KwaZulu Natal province, (File photo).
Jessica Berman
Studies show a short course of an inexpensive anti-tuberculosis drug can dramatically reduce transmission of the bacterial respiratory disease.  That's why many public health experts promote the use of the single antibiotic - called isoniazid - in communities with large populations of HIV-infected individuals -- people with notoriously high rates of secondary TB infections.  Researchers, however, caution that widespread use of isoniazid could speed the emergence of drug-resistant strains of TB. 

The World Health Organization recommends giving a six-month course of isoniazid preventive therapy (IPT) to three groups of people at risk of becoming infected with tuberculosis and spreading it to others.  Included were individuals infected with HIV, the virus that causes AIDS; children under the age of five with immature immune systems; and people who have been exposed to tuberculosis and test positive for the disease.

In studies using short course anti-TB therapy, results have been impressive, according to Mario Raviglione, director of the World Health Organization’s Stop-TB office.

Raviglione says IPT suppresses TB infection in 60 to 70 percent of HIV-negative individuals and 80 to 90 percent of those with HIV.

“You just don’t become infectious to others and [you] yourself are not affected by the disease,” he said.

Despite the demonstrated effectiveness of isoniazid preventative therapy, Raviglione says it’s rarely used.  He notes that IPT is limited to about 400,000 HIV-infected individuals, a fraction of the eight million people living with HIV globally who are at highest risk of becoming infected with TB.  And he says the single-drug therapy is almost never used in children or others exposed to TB.

But with an estimated one-third of the world’s population infected with a latent form of TB that could become active -- and lethal -- at any time, some international public health officials have proposed using isoniazid prophylaxis, or prevention, in entire at-risk communities throughout the developing world.

Others, like Caroline Colijn, think such widespread use of isoniazid mono-therapy to contain TB is potentially too risky.  

Colijn, of Imperial College London, and colleagues constructed a mathematical model that shows how blanketing a community with a single anti-TB drug, such as isoniazid in IPT, paves the way for the eventual emergence of drug-resistant strains of the TB bacterium.

“We don’t argue against doing IPT.  It’s probably one of the best interventions we have against TB," he noted. "But we would definitely argue that we need to consider these long-term consequences and roll out appropriate treatment for resistant TB and treatment for TB.”

The WHO’s Raviglione agrees, saying the key to a successful tuberculosis prevention strategy is making sure people who are actively infected with TB are not treated with a single drug.

“This mathematical model doesn’t change our concern because we knew if you are not doing a proper job in screening out, in ruling out, active tuberculosis when you start prophylaxis, then you run the concrete risk of developing drug resistance in that very person,” he explained.

An article describing the risks of promoting drug-resistant forms of tuberculosis with the widespread use of Isoniazid Preventive Therapy against TB appears in the journal Science Translational Medicine.

You May Like

US Imposes Sanctions on Alleged Honduran Drug Gang

Treasury department alleges Los Valles group is responsible for smuggling tens of thousands of kilograms of cocaine into US each month More

At 91, Marvel Creator Stan Lee Continues to Expand his Universe

Company's chief emeritus hopes to interest new generation of children in superheroes of all shapes and sizes by publishing content across multiple media platforms More

Photogallery New Drug Protects Against Virus in Ebola Family

Study by researchers at University of Texas Medical Branch, Tekmira Pharmaceuticals is first looking at drug's effectiveness after onset of symptoms More

Featured Videos

Your JavaScript is turned off or you have an old version of Adobe's Flash Player. Get the latest Flash player.
Five Patients Given Experimental Ebola Drug Said to Be Improvingi
X
Carol Pearson
August 19, 2014 11:43 PM
The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video Five Patients Given Experimental Ebola Drug Said to Be Improving

The World Health Organization has approved the use of experimental treatments for Ebola patients in West Africa. The Ebola outbreak there is unprecedented, the disease deadly. The number of people who have died from Ebola has surpassed 1,200. VOA's Carol Pearson reports on the ethical considerations of allowing experimental drugs to be used.
Video

Video In Ukraine, Fear and Distrust Remain Where Fighting has Stopped

As the Ukrainian military reclaims control of eastern cities from pro-Russian separatists, residents are getting a chance to rebuild their lives. VOA's Gabe Joselow reports from the town of Kramatorsk in Donetsk province, where a sense of fear is still in the air, and distrust of the government in Kyiv still runs deep.
Video

Video China Targets Overseas Assets of Corrupt Officials

As China presses forward with its anti-graft effort, authorities are targeting corrupt officials who have sent family members and assets overseas. The efforts have stirred up a debate at home on exactly how many officials take that route and how likely it is they will be caught. Rebecca Valli has this report.
Video

Video Leading The Fight Against Islamic State, Kurds Question Iraqi Future

Western countries including the United States have begun arming the Kurdish Peshmerga forces in northern Iraq to aid their battle against extremist Sunni militants from the Islamic State. But there are concerns that a heavily-armed Kurdistan Regional Government, or KRG, might seek to declare independence and cause the break-up of the Iraqi state. As Henry Ridgwell reports from London, the KRG says it will only seek greater autonomy from Baghdad.
Video

Video In Rural Kenya, Pressure Builds Against Female Circumcision

In some Kenyan communities, female genital mutilation remains a rite of passage. But activists are pushing back, with education for girls and with threats of punishment those who perform the circumcision. Mohammed Yusuf looks at the practice in the rural eastern community of Tharaka-Nithi.
Video

Video For Obama, Racial Violence is Personal Issue

The racial violence in the St. Louis suburb of Ferguson is presenting U.S. President Barack Obama with an issue to which he has a deep personal connection. To many Americans, Obama's election as America's first black president marked a turning point in race relations in the United States, and Obama has made ending the violence a policy priority. On Monday he issued a new call for calm and understanding. Luis Ramirez reports from the White House.
Video

Video Clinton-Obama Relationship Could Impact 2016 Election

President Barack Obama and former Secretary of State Hillary Clinton have a long and complicated relationship. That relationship took another turn recently when Clinton criticized the president’s foreign policy. VOA National Correspondent Jim Malone reports there is renewed attention on the Clinton-Obama relationship as Hillary Clinton considers running for
Video

Video Iran Looks to Maintain Influence in Baghdad With New Shia PM

Washington and Tehran share the goal of stopping Syrian-based militants in Iraq. But experts say it's Iran, not the United States, that will most influence how the new government in Baghdad approaches internal reforms and the war in Syria. VOA State Department Correspondent Scott Stearns has the story.

AppleAndroid